HealthcareServices

Pleural Diseases Market Performance Outlook 2026–2030: Revenue to Hit $7.35 Billion at 7.1% CAGR

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pleural diseases market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Pleural Diseases Market in 2030?

The pleural diseases market size has experienced robust growth in recent years. It is projected to expand from $5.21 billion in 2025 to $5.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.3%. This historical expansion can be linked to several factors, including the increasing incidence of respiratory diseases, a rising prevalence of pleural effusion and mesothelioma, enhanced availability of diagnostic imaging, the expansion of pulmonology services, and an increase in hospital-based respiratory care.

The pleural diseases market size is projected to experience significant expansion in the coming years. It is forecasted to reach $7.35 billion by 2030, expanding at a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is attributed to factors such as increasing investments in early cancer detection, a rising demand for minimally invasive diagnostics, the expansion of precision medicine approaches, a growing focus on outpatient respiratory care, and advancements in pleural disease therapeutics. Key trends during this period include the increasing adoption of advanced imaging diagnostics, the rising use of minimally invasive pleural interventions, the growing integration of molecular diagnostic tools, the expansion of early disease detection programs, and an enhanced focus on personalized treatment approaches.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Drivers Are Influencing Production Trends In The Pleural Diseases Market?

A rise in the occurrence of infectious diseases is anticipated to propel the expansion of the pleural diseases market in the future. These diseases are conditions resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites. Alterations in environmental factors impacting human behavior and improvements in worldwide travel contribute to the growing incidence of infectious diseases. Conditions like bacterial pneumonia, tuberculosis, or viral infections, being infectious diseases, are capable of inducing pleural disease through the initiation of inflammation, infection, or fluid buildup within the pleural cavity. For example, in January 2023, data from the National Library of Medicine, a US-based medical library offering research and information, indicated that infectious diseases are responsible for more than 52 million deaths each year, endangering half of the global population. Moreover, roughly 14 million children under the age of five perish annually, and 70% of these fatalities stem from illnesses preventable by vaccination. Consequently, the expanding occurrence of infectious diseases fuels the growth of the pleural diseases market.

Which Segment Groups Are Influencing The Pleural Diseases Market?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Benign Pleural Tumors, Pleural Thickening Disorders, Pleural Plaques

5) By Other Disease Types: Empyema, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Which Trends Are Influencing The Development Of The Pleural Diseases Market?

Major companies operating in the pleural diseases market are concentrating on developing advanced treatment alternatives, such as convenient, ready-to-administer injectable therapies, to boost user convenience, cut down on preparation time, and reduce potential dosing errors. These ready-to-use injectable treatments are pre-formulated and pre-diluted medications that do not require reconstitution or mixing before being administered, thus ensuring accuracy, ease of use, and faster preparation. As an example, in April 2024, Amneal Pharmaceuticals, a pharmaceutical company based in the US, unveiled PEMRYDI RTU, which is the first ready-to-use formulation of pemetrexed for injection. This innovation assists individuals with pleural diseases by offering a convenient, immediately usable treatment that removes the necessity for reconstitution or dilution, decreases preparation time, lessens the risk of dosing errors, and improves availability of effective therapy for conditions such as malignant pleural mesothelioma.

Who Are The Top-Performing Companies In The Pleural Diseases Market In Recent Years?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Region Currently Holds The Largest Share Of The Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pleural Diseases Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

Browse Through More Reports Similar to the Global Pleural Diseases Market 2026, By The Business Research Company

Interstitial Lung Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/interstitial-lung-disease-global-market-report

Aortic Aneurysm Market Report 2026

https://www.thebusinessresearchcompany.com/report/aortic-aneurysm-global-market-report

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795